Publicaciones en colaboración con investigadores/as de University of Sassari (13)

2023

  1. Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy

    Gut, Vol. 73, Núm. 3, pp. 496-508

  2. eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation

    Journal of Infection in Developing Countries, Vol. 14, Núm. 3, pp. 265-267

2018

  1. Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes

    Journal of the American College of Cardiology, Vol. 71, Núm. 3, pp. 279-288

2016

  1. Defining immunological dysfunction in sepsis: A requisite tool for precision medicine

    Journal of Infection, Vol. 72, Núm. 5, pp. 525-536

2015

  1. A global reference for human genetic variation

    Nature, Vol. 526, Núm. 7571, pp. 68-74

2014

  1. Immune response to influenza A(H1N1)v in HIV-infected patients

    Journal of Infection in Developing Countries, Vol. 8, Núm. 1, pp. 101-109

  2. Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel

    Nature Communications, Vol. 5

2012

  1. An integrated map of genetic variation from 1,092 human genomes

    Nature, Vol. 491, Núm. 7422, pp. 56-65

  2. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection

    PLoS ONE, Vol. 7, Núm. 6

2011

  1. Inflammatory cytokine expression is associated with Chikungunya virus resolution and symptom severity

    PLoS Neglected Tropical Diseases, Vol. 5, Núm. 8

2010

  1. Host adaptive immunity deficiency in severe pandemic influenza

    Critical Care, Vol. 14, Núm. 5